PSNL
Personalis, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Personalis has 0 disclosed suppliers and 4 disclosed customers in SEC filings.
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
0.00%
vs ±10.9% implied · ×0.00
shaded = implied · ▲▼ = realized
SentenceThe following table shows customers that made up at least 10% of total revenue in each year presented:
Year Ended December 31,
2025
2024
Moderna, Inc.
22%
28%
basisPSNL FY2025 revenue $70MMRNA FY2025 revenue $1.9B
Sentenceour sales, marketing and commercialization plans and strategies, including the expected benefits of and activities to be performed under our Commercialization and Reference Laboratory Agreement with Tempus AI, Inc. ("Tempus");
PSNL 10-Kaccession 0001193125-26-076615
Sentenceour future business with the U.S. Department of Veterans Affairs' Million Veteran Program ("VA MVP"), ModernaTX, Inc. ("Moderna"), Merck & Co., Inc. ("Merck"), and other collaboration partners and customers;
PSNL 10-Kaccession 0001193125-26-076615
Personalis, Inc.
15.83
—
Expected move
Inputs8Q avg ±9.9%·×1.03·fair
straddle ±11.8%
spot 15.82exp Nov 20ATM strike 15ATM straddle 2.20IV 71%